This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Oxford Biomedica (UK) Limited, Ucl Business Plc. Active years: 2008-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2017
Title: Mary Collins - Innovator in Lentiviral and Retroviral Technologies
Introduction
Mary Collins is a prominent inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the development of lentiviral and retroviral vectors. With a total of 3 patents to her name, her work has implications for clinical trials and therapeutic applications.
Latest Patents
Mary Collins' latest patents include innovative materials and methods relating to packaging cell lines. One of her notable inventions involves lentiviral packaging cells capable of producing lentiviral vectors suitable for use in clinical trials. Additionally, she has developed a retroviral vector that can express a nucleotide of interest, which encodes an RNA or protein harmful to a cell.
Career Highlights
Throughout her career, Mary has worked with leading companies in the biotechnology sector, including Oxford Biomedica Limited and UCL Business Plc. Her expertise in the field has allowed her to contribute to advancements in gene therapy and vector development.
Collaborations
Mary has collaborated with esteemed colleagues such as Yasuhiro Takeuchi and Kyriacos Andreou Mitrophanous. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Mary Collins is a trailblazer in the biotechnology industry, with her patents paving the way for advancements in clinical applications. Her work continues to influence the development of innovative solutions in gene therapy and vector technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile